Renal Business Today - Type 2 Diabetes

BMI Better Than Waist Circumference to Predict Type 2 Diabetes in Kids

ANN ARBOR, Mich.—Waist circumference, a measure of belly fat, is not a better predictor than body mass index for identifying children with an increased risk of developing type 2 diabetes, according to a study published online Aug. 19 in the Journal of Adolescent Health. ...More

August 23, 2011

Posted in News, Clinical & Pharma

Study Finds Way for White Fat to Burn Energy

WASHINGTON—National Institutes of Health (NIH) scientists have uncovered a pathway in mice that allows white fat—a contributor to obesity and type 2 diabetes—to burn calories in a way that’s normally found in brown fat and muscle, according to a study in the July 6 edition ...More

July 5, 2011

Posted in News, Clinical & Pharma

Drug Improves Kidney Function in Diabetics

PRAGUE—Type 2 diabetics receiving the drug bardoxolone methyl experiences sustained improvement in their kidney function over the course of a 52-week treatment period, according to a phase 2 study published online June 24 in the New England Journal of Medicine. ...More

June 24, 2011

Posted in News, Clinical & Pharma

NKF Plans to Study CKD Prevalence in Type 2 Diabetics

NEW YORK—In an effort to estimate the prevalence of chronic kidney disease in adults with type 2 diabetes and examine the care of these individuals, the National Kidney Foundation is launching a multi-site cross-sectional study, “Awareness, Detection and Drug Therapy in ...More

May 17, 2011

Posted in News, Clinical & Pharma

Low Carb Diet May Reverse Kidney Failure in Diabetics

NEW YORK—The ketogenic diet, a specialized high-fat, low carbohydrate diet, may reverse impaired kidney function in people with type 1 and type 2 diabetes, according to a study in the current issue of PLoS ONE. ...More

April 20, 2011

Posted in News, Clinical & Pharma

Drug Prevents Type 2 Diabetes in High-Risk Individuals

SAN ANTONIO—A pill taken once a day in the morning prevented type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease, according to a study published March 24 in the New England Journal of ...More

March 24, 2011

Posted in News, Clinical & Pharma

NIH Has Plan to Combat Diabetes

WASHINGTON—The National Institutes of Health (NIH) has released a new strategic plan to guide diabetes-related research over the next decade. ...More

March 21, 2011

Posted in News, Clinical & Pharma, Government & Regulation

Cheaper, Older Type 2 Diabetes Drug Works as Well as Newer Drugs

BALTIMORE—An inexpensive type 2 diabetes drug that has been around for more than 15 years works just as well and has fewer side effects than a half-dozen other, mostly newer and more expensive classes of medication used to control the chronic disease, according to a study ...More

March 15, 2011

Posted in News, Clinical & Pharma

Missing Sugar Molecule Raises Diabetes Risk in Humans

SAN DIEGO—An evolutionary gene mutation that occurred in humans millions of years ago and our subsequent inability to produce a specific kind of sialic acid molecule appears to make people more vulnerable to developing type 2 diabetes, especially if they’re overweight, ...More

February 28, 2011

Posted in News, Clinical & Pharma

FDA OKs Kidney Disease Update for Onglyza

PRINCETON, N.J.—The U.S. Food ad Drug Administration (FDA) has approved the inclusion of data from kidney disease clinical studies in the label for the type 2 diabetes drug Onglyza, according to Bristol-Myers Squibb Company and AstraZeneca. ...More

February 24, 2011

Posted in News, Clinical & Pharma, Government & Regulation

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Type 2 Diabetes

Mobile Health Snaps

Galleries

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail